Cargando…

Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study

SIMPLE SUMMARY: Recent ESC Atrial Fibrillation guidelines introduced some changes in the options for rate control, such as the possibility to combine beta-blockers and non-dihydropyridine calcium channel blockers to address the need for a personalised pharmacologic rate control treatment for AF. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diemberger, Igor, Spadotto, Alberto, Massaro, Giulia, Amadori, Martina, Damaschin, Liviu, Martignani, Cristian, Ziacchi, Matteo, Biffi, Mauro, Galiè, Nazzareno, Boriani, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855170/ https://www.ncbi.nlm.nih.gov/pubmed/36671715 http://dx.doi.org/10.3390/biology12010022

Ejemplares similares

Personalized rate control treatment for atrial fibrillation: a prospective case-control study on the use of diltiazem
por: Spadotto, A, et al.
Publicado: (2023)

New left ventricular active fixation lead: The experience of lead extraction
por: Ziacchi, Matteo, et al.
Publicado: (2015)

Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only?
por: Biffi, Mauro, et al.
Publicado: (2016)

Telecardiology and Remote Monitoring of Implanted Electrical Devices: The Potential for Fresh Clinical Care Perspectives
por: Boriani, Giuseppe, et al.
Publicado: (2007)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database
por: Boriani, Giuseppe, et al.
Publicado: (2016)

Evolution of surface and endocavitary signals in patients with arrhythmogenic cardiomyopathy at 1 and 5 years
por: Martignani, C, et al.
Publicado: (2023)

Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads
por: Ziacchi, M., et al.
Publicado: (2018)

Run baby run … but not too fast! Rate control management in atrial fibrillation: a claim for personalization
por: Diemberger, Igor, et al.
Publicado: (2023)

The last shall be the first: the role of combined QLV- and CMR-determined electromechanical concordance in predicting optimal left ventricular stimulation site in cardiac resynchronisation therapy
por: Bertelli, M, et al.
Publicado: (2023)

The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia
por: Gatti, Milo, et al.
Publicado: (2020)

Novelty about pocket histology at cardiac implantable electronic device reopening procedures
por: Massaro, G, et al.
Publicado: (2023)

QRS pattern and improvement in right and left ventricular function after cardiac resynchronization therapy: a radionuclide study
por: Domenichini, Giulia, et al.
Publicado: (2012)

Is Less Always More? A Prospective Two-Centre Study Addressing Clinical Outcomes in Leadless versus Transvenous Single-Chamber Pacemaker Recipients
por: Bertelli, Michele, et al.
Publicado: (2022)

Correction: Bertelli et al. Is Less Always More? A Prospective Two-Centre Study Addressing Clinical Outcomes in Leadless versus Transvenous Single-Chamber Pacemaker Recipients. J. Clin. Med. 2022, 11, 6071
por: Bertelli, Michele, et al.
Publicado: (2023)

Rate control with intravenous diltiazem, verapamil, and metoprolol in acute atrial fibrillation with rapid ventricular rate
por: Medeiros, Tia, et al.
Publicado: (2021)

Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2021)

Publisher’s note to: Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2022)

Diltiazem Dosing Strategies in the Management of Atrial Fibrillation With Rapid Ventricular Rate
por: Bishop, James, et al.
Publicado: (2021)

Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing
por: Diemberger, Igor, et al.
Publicado: (2023)

Cardiac Arrest Following Treatment With Diltiazem for Atrial Fibrillation With Rapid Ventricular Response
por: Lee, Woo Kyung, et al.
Publicado: (2020)

Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
por: Xu, Yunwen, et al.
Publicado: (2022)

Atrial Remodeling: Evolving Concepts
por: Biffi, Mauro, et al.
Publicado: (2003)

Comparison of diltiazem and metoprolol for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis
por: Sharda, Saurabh C., et al.
Publicado: (2022)

His Bundle pacing for congenital complete AV block: An attempt to fix a broken heart?
por: Piemontese, Giuseppe Pio, et al.
Publicado: (2022)

Diltiazem Prophylaxis for the Prevention of Atrial Fibrillation in Patients Undergoing Thoracoabdominal Esophagectomy: A Retrospective Cohort Study
por: Hochreiter, Marcel, et al.
Publicado: (2020)

Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria
por: Rahbar Kouibaran, Farzad, et al.
Publicado: (2023)

Diltiazem efficacy and CYP2D6 gene polymorphism in patients with atrial fibrillation with rapid ventricular response
por: Uluturk, Mehmet, et al.
Publicado: (2023)

Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2016)

An international two-centre experience with the third generation laser balloon system: safety, efficiency, and efficacy
por: Martignani, C, et al.
Publicado: (2023)

The Impact of COVID-19 Pandemic and Lockdown Restrictions on Cardiac Implantable Device Recipients with Remote Monitoring
por: Diemberger, Igor, et al.
Publicado: (2021)

Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2017)

Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function
por: Pham, Phuong, et al.
Publicado: (2020)

Design and development of controlled porosity osmotic tablet of diltiazem hydrochloride
por: Shahi, Sadhana R., et al.
Publicado: (2012)

Role of Magnesium Alone or in Combination with Diltiazem and/or Amiodarone in prevention of Atrial Fibrillation following Off-Pump Coronary Artery Bypass Grafting
por: Tempe, Deepak K., et al.
Publicado: (2023)

Vascular Accesses in Cardiac Stimulation and Electrophysiology: An Italian Survey Promoted by AIAC (Italian Association of Arrhythmias and Cardiac Pacing)
por: Ziacchi, Matteo, et al.
Publicado: (2022)

Safety and Efficacy of Prehospital Diltiazem
por: Luk, Jeffrey H., et al.
Publicado: (2013)

Diltiazem-associated Photodistributed Hyperpigmentation
por: Siegel, Jacob D., et al.
Publicado: (2020)

Failure of diltiazem to prevent 1:1 conduction of atrial flutter: a case report
por: Tiver, K. D., et al.
Publicado: (2023)

Subacute pericardial abscess after aortic valve replacement: a case report
por: Magnani, Ilenia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vtro86kpr2l2qifk7tfbl93veg